サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1427876

左心室補助装置の世界市場レポート 2024年

Left Ventricular Assist Devices Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
左心室補助装置の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

左心室補助装置の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.8%の年間複合成長率（CAGR）で23億米ドルに成長すると予想されます。予測期間で予想される成長は、左心室補助装置の適応症の拡大、心不全症例の増加、患者転帰の改善、市場承認と規制変更、目的治療への焦点など、さまざまな要因によるものと考えられます。予測期間に予想される主要動向としては、埋め込み技術の進歩、デュアルポンプシステムの開発、目的地療法としての左心室補助装置の使用への注目の高まり、感染リスクを最小限に抑える取り組み、心不全管理プログラムとの統合、抗凝固療法の改善などが挙げられます。管理。

左心室補助装置市場の予想される成長は、心血管疾患の有病率の上昇によって促進されると予想されます。心血管疾患には、冠状動脈性心疾患や先天性心疾患などの心臓と血管に影響を及ぼす一連の疾患が含まれます。進行した心不全の場合、左心室補助装置は、身体の組織に血液を送り出す役割を担う左心室の機能をサポートする上で重要な役割を果たします。たとえば、世界心臓連盟（WHF）が2022年10月に発表したデータでは、心血管疾患（CVD）による死亡者数が2020年の推定1,890万人から2030年には2,220万人以上に増加すると予測されています。米国では、心臓病が人の命を奪っています。年間約69万7,000人が死亡し、5人に1人が心臓病による死亡者であり、毎年約80万5,000人のアメリカ人が心臓発作を経験しています。このうち、60万5,000人が初めての心臓発作であり、20万人は以前の心臓発作が原因となっています。したがって、心血管疾患の有病率の上昇は、左心室補助装置市場の成長の重要な推進力となっています。

医療費の増加も、左心室補助装置市場の成長を促進すると予想されるもう1つの要因です。医療費には、健康に重点を置いた医療サービス、家族計画活動、栄養プログラム、緊急援助の提供に関連するすべての費用が含まれます。医療支出の増加は、左心室補助装置を含むさまざまな健康関連製品の進歩と開発をサポートしています。 2023年 2月、メディケアとメディケイドサービスセンターは、米国の医療支出が2.7%増加し、2021年には4兆3,000億米ドル、つまり1人当たり1万2,914ドルに達したと報告しました。医療支出は国のGDPの18.3%を占めました。この医療費の急増は、左心室補助装置市場全体の成長に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の左心室補助装置市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の左心室補助装置の市場規模実績と成長率、2018～2023年
  • 世界の左心室補助装置市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の左心室補助装置市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 経皮型
  • 植込型
  • 世界の左心室補助装置市場、フローのタイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 拍動性
  • 非拍動性
  • 世界の左心室補助装置市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • BTR（Bridge-to-Recovery）療法
  • BTT（Bridge-to-Transplant）療法
  • 植込型補助人工心臓療法
  • BTC（Bridge-to-Candidacy）療法
  • 世界の左心室補助装置市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 心臓病センター
  • 病院

第7章 地域と国の分析

  • 世界の左心室補助装置市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の左心室補助装置市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 左心室補助装置市場の競合情勢
  • 左心室補助装置市場の企業プロファイル
    • Abbott Laboratories
    • Medtronic plc.
    • Terumo Corporation
    • St. Jude Medical
    • MAQUET GmbH &Co.

第31章 その他の大手と革新的な企業

  • Saft
  • LivaNova Plc
  • Thoratec Corporation
  • Abiomed Inc
  • Heart Ware International Inc.
  • Transonic Systems
  • Berlin Heart GmbH
  • BioVentrix
  • Cleveland Heart Inc.
  • Jarvik Heart Inc.
  • CorWave SA
  • SynCardia Systems LLC
  • NuPulseCV Inc.
  • Fineheart
  • Procyrion Inc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13720

A left ventricular assist device (LVAD) serves as a mechanical pump implanted in heart failure patients, assisting the heart's lower left chamber (left ventricle) in pumping blood to the aorta and throughout the body.

The primary types of left ventricular assist devices include transcutaneous left ventricular assist devices and implantable left ventricular assist devices. A transcutaneous left ventricular assist device is characterized by having both an external power supply and an internal pump located inside the body. Tubes connect the pump to the heart through small openings in the abdomen. This type of LVAD is often employed for short-term support during or following surgery. Left ventricular assist devices can have either pulsatile or non-pulsatile flows, and they are used in various therapeutic approaches such as bridge-to-recovery (BTR) therapy, bridge-to-transplant (BTT) therapy, destination therapy, and bridge-to-candidacy (BTC) therapy. Cardiology centers and hospitals typically utilize these devices for patient care.

The left ventricular assist devices market research report is one of a series of new reports from The Business Research Company that provides left ventricular assist devices market statistics, including the left ventricular assist devices industry's global market size, regional shares, competitors with a left ventricular assist devices market share, detailed left ventricular assist devices market segments, market trends, and opportunities, and any further data you may need to thrive in the left ventricular assist devices industry. This left ventricular assist devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.5 billion in 2023 to $1.64 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth observed in the historic period can be attributed to several factors, including the implementation of post-market surveillance and data, advancements leading to a reduction in device size and noise, awareness and education programs, increased physician experience, and the adoption of left ventricular assist devices in bridge therapy.

The left ventricular assist devices market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period can be attributed to various factors, including the expansion of indications for left ventricular assist devices, an increase in heart failure cases, improvements in patient outcomes, market approvals and regulatory changes, and a focus on destination therapy. Major trends expected in the forecast period include advancements in implantation techniques, the development of dual-pump systems, an increased focus on the use of left ventricular assist devices as destination therapy, efforts to minimize infection risks, integration with heart failure management programs, and improvements in anticoagulation management.

The anticipated growth in the left ventricular assist device market is expected to be propelled by the rising prevalence of cardiovascular diseases. Cardiovascular diseases encompass a group of disorders affecting the heart and blood vessels, including conditions such as coronary heart disease and congenital heart disease. In cases of advanced heart failure, left ventricular assist devices play a crucial role in supporting the left ventricle's function, which is responsible for pumping blood to the body's tissues. For example, data from the World Heart Federation (WHF) in October 2022 projected an increase in cardiovascular disease (CVD) deaths from an estimated 18.9 million in 2020 to over 22.2 million in 2030. In the United States, heart disease claims the lives of approximately 697,000 people annually, with 1 in every 5 fatalities attributed to heart disease, and around 805,000 Americans experiencing a heart attack each year. Of these, 605,000 are first-time heart attacks, while 200,000 are caused by previous heart attacks. Consequently, the rising prevalence of cardiovascular diseases is a significant driver for the growth of the left ventricular assist device market.

The increase in healthcare expenditures is another factor expected to drive the growth of the left ventricular assist device market. Healthcare expenditures encompass all costs associated with providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. The growth in healthcare expenditures supports the advancement and development of various health-related products, including left ventricular assist devices. In February 2023, the Centers for Medicare & Medicaid Services reported a 2.7% increase in healthcare spending in the United States, reaching $4.3 trillion or $12,914 per person in 2021. Healthcare spending accounted for 18.3% of the country's GDP. This surge in healthcare expenditures contributes to the overall growth of the left ventricular assist device market.

Technological advancements are a prominent and growing trend in the left ventricular assist device market, with major companies adopting innovative technologies to maintain their positions in the market. For instance, in January 2021, CorWave SA, a France-based medical device company specializing in innovative heart pumps, introduced left ventricular assist device (LVAD) membrane pump technology. This LVAD utilizes a pulse pump with electromagnetic pulses instead of a rotary pump to flow blood, closely replicating the natural heartbeat and producing a pulsatile pumping activity.

Major companies in the left ventricular assist device industry are significantly investing in research, development, and early feasibility trials for their Total Artificial Heart (TAH). This substantial investment aligns with long-term goals, as demonstrated by BiVACOR, a US-based medical technology company that secured $18 million in funding for TAH development in March 2023. Led by Cormorant Asset Management and OneVentures, these funds will support research, early feasibility trials, and key executive hires. The BiVACOR TAH, designed for severe biventricular heart failure, incorporates advancements from Left Ventricular Assist Device (LVAD) technology, signaling a shift toward durable rotary blood pumps.

In December 2022, Johnson & Johnson, a prominent US-based pharmaceutical and medical technology company, completed the acquisition of Abiomed Inc for $16.6 billion. This strategic acquisition aimed to expand Johnson & Johnson's presence in the high-growth cardiovascular markets. Abiomed Inc., a US-based medical device technology company, specializes in providing circulatory and oxygenation support devices, including ventricular assist technology that pumps blood from the left ventricle (LV).

Major companies operating in the left ventricular assist devices market report are Abbott Laboratories, Medtronic plc., Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., Saft, LivaNova PLC, Thoratec Corporation, Abiomed Inc., Heart Ware International Inc., Transonic Systems, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc., Carmat SA, BiVACOR Inc., Cardiac Assist Inc., Leviticus Cardio Ltd., AdjuCor GmbH, Calon Cardio-Technology Ltd., Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc., Sun Medical Technology Research Corp

North America was the largest region in the left ventricular assist devices market in 2023. The regions covered in the left ventricular assist devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the left ventricular assist devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The left ventricular assist devices market consists of sales of rechargeable left ventricular assist devices, non-rechargeable left ventricular assist devices, heart pumps, and controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Left Ventricular Assist Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on left ventricular assist devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for left ventricular assist devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The left ventricular assist devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Transcutaneous Left Ventricular Assist Devices; Implantable Left Ventricular Assist Devices
  • 2) By Type of Flow: Pulsatile; Non-Pulsatile
  • 3) By Application: Bridge-to-Recovery (BTR) Therapy; Bridge-to-Transplant (BTT) Therapy; Destination Therapy; Bridge-to-Candidacy (BTC) Therapy
  • 4) By End-user: Cardiology Centers; Hospitals
  • Companies Mentioned: Abbott Laboratories; Medtronic plc.; Terumo Corporation; St. Jude Medical; MAQUET GmbH & Co.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Left Ventricular Assist Devices Market Characteristics

3. Left Ventricular Assist Devices Market Trends And Strategies

4. Left Ventricular Assist Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Left Ventricular Assist Devices Market Size and Growth

  • 5.1. Global Left Ventricular Assist Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Left Ventricular Assist Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Left Ventricular Assist Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Left Ventricular Assist Devices Market Segmentation

  • 6.1. Global Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Transcutaneous Left Ventricular Assist Devices
  • Implantable Left Ventricular Assist Devices
  • 6.2. Global Left Ventricular Assist Devices Market, Segmentation By Type of Flow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pulsatile
  • Non-Pulsatile
  • 6.3. Global Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bridge-to-Recovery (BTR) Therapy
  • Bridge-to-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge-to-Candidacy (BTC) Therapy
  • 6.4. Global Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiology Centers
  • Hospitals

7. Left Ventricular Assist Devices Market Regional And Country Analysis

  • 7.1. Global Left Ventricular Assist Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Left Ventricular Assist Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Left Ventricular Assist Devices Market

  • 8.1. Asia-Pacific Left Ventricular Assist Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Left Ventricular Assist Devices Market

  • 9.1. China Left Ventricular Assist Devices Market Overview
  • 9.2. China Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Left Ventricular Assist Devices Market

  • 10.1. India Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Left Ventricular Assist Devices Market

  • 11.1. Japan Left Ventricular Assist Devices Market Overview
  • 11.2. Japan Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Left Ventricular Assist Devices Market

  • 12.1. Australia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Left Ventricular Assist Devices Market

  • 13.1. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Left Ventricular Assist Devices Market

  • 14.1. South Korea Left Ventricular Assist Devices Market Overview
  • 14.2. South Korea Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Left Ventricular Assist Devices Market

  • 15.1. Western Europe Left Ventricular Assist Devices Market Overview
  • 15.2. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Left Ventricular Assist Devices Market

  • 16.1. UK Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Left Ventricular Assist Devices Market

  • 17.1. Germany Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Left Ventricular Assist Devices Market

  • 18.1. France Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Left Ventricular Assist Devices Market

  • 19.1. Italy Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Left Ventricular Assist Devices Market

  • 20.1. Spain Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Left Ventricular Assist Devices Market

  • 21.1. Eastern Europe Left Ventricular Assist Devices Market Overview
  • 21.2. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Left Ventricular Assist Devices Market

  • 22.1. Russia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Left Ventricular Assist Devices Market

  • 23.1. North America Left Ventricular Assist Devices Market Overview
  • 23.2. North America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Left Ventricular Assist Devices Market

  • 24.1. USA Left Ventricular Assist Devices Market Overview
  • 24.2. USA Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Left Ventricular Assist Devices Market

  • 25.1. Canada Left Ventricular Assist Devices Market Overview
  • 25.2. Canada Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Left Ventricular Assist Devices Market

  • 26.1. South America Left Ventricular Assist Devices Market Overview
  • 26.2. South America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Left Ventricular Assist Devices Market

  • 27.1. Brazil Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Left Ventricular Assist Devices Market

  • 28.1. Middle East Left Ventricular Assist Devices Market Overview
  • 28.2. Middle East Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Left Ventricular Assist Devices Market

  • 29.1. Africa Left Ventricular Assist Devices Market Overview
  • 29.2. Africa Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Left Ventricular Assist Devices Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Left Ventricular Assist Devices Market Competitive Landscape And Company Profiles

  • 30.1. Left Ventricular Assist Devices Market Competitive Landscape
  • 30.2. Left Ventricular Assist Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic plc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Terumo Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. St. Jude Medical
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. MAQUET GmbH & Co.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Left Ventricular Assist Devices Market Other Major And Innovative Companies

  • 31.1. Saft
  • 31.2. LivaNova Plc
  • 31.3. Thoratec Corporation
  • 31.4. Abiomed Inc
  • 31.5. Heart Ware International Inc.
  • 31.6. Transonic Systems
  • 31.7. Berlin Heart GmbH
  • 31.8. BioVentrix
  • 31.9. Cleveland Heart Inc.
  • 31.10. Jarvik Heart Inc.
  • 31.11. CorWave SA
  • 31.12. SynCardia Systems LLC
  • 31.13. NuPulseCV Inc.
  • 31.14. Fineheart
  • 31.15. Procyrion Inc

32. Global Left Ventricular Assist Devices Market Competitive Benchmarking

33. Global Left Ventricular Assist Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Left Ventricular Assist Devices Market

35. Left Ventricular Assist Devices Market Future Outlook and Potential Analysis

  • 35.1 Left Ventricular Assist Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Left Ventricular Assist Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Left Ventricular Assist Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer